Nesta Impact Investments leads £500k Series A round in Genera

www.nesta.org.uk/press-release/nesta-impact-investments-leads-500k-series-a-round-in-genera/
Skip to content

Social impact investor Nesta Impact Investments (NII) has led a £500k Series A funding round in Genera, a fast-growing healthcare technology company whose 'Synopsis' platform facilitates seamless patient assessment and risk evaluation ahead of surgery, adding to its health portfolio. The investment was made alongside GSTC Health Innovations Limited, part of Guy’s and St Thomas’ Charity, and will be used to scale Genera’s reach and impact in the UK by strengthening its customer experience and business development teams.

The investment is the latest addition to Nesta’s healthcare portfolio and forms part of the strategy to invest in products and services that help improve health and wellbeing outcomes in the UK, especially for older people and disadvantaged groups. Genera sits alongside existing investments in Oomph and Reconnections which provide activity management services for older people. Nesta will hold a position on the board.

Genera is the market leader in software for the Perioperative Surgical Home (PSH) and its products are used as a patient assessment and risk evaluation tool in NHS hospital trusts and private clinics. Nesta’s investment will help the business to expand its activities into more hospitals across the UK and in Europe, improving patient health outcomes by helping to reduce cancellations, delays, risk and errors in surgery. 

Manish Miglani, Healthcare Lead at Nesta Impact Investments, comments: “Nesta’s health investment activity focuses on innovative and scalable care solutions and technologies that improve health outcomes and reduce health inequalities.  We backed Genera because there is good evidence that an effective pre-operative risk assessment tool is a strong predictor for better surgical outcomes. We are excited to have led this very significant investment round and look forward to supporting management’s scale-up plans for the company.”

Thomas Hurrell, Genera Chief Executive Officer, added: “We are delighted to welcome Nesta Impact Investments and GSTC not only as investors but as partners. This significantly strengthened position allows us to deliver on our strategic plan more quickly, and to scale the impact we are already having. ‘Synopsis’ is touching more lives than ever and this round will enable us to accelerate growth whilst investing in great client and patient experiences. This will lead to better outcomes and health for more people, which is our ultimate goal."

For more information about Nesta Impact Investments and to speak to the team please visit www.nestainvestments.org.uk.

-ENDS-

About Nesta Impact Investments: A £17.6 million impact investment fund supported by Big Society Capital, Omidyar Network and Nesta. Launched in October 2012 NII helps tackle the major challenges faced by older people, children and communities in the UK by investing in life-changing innovations. The fund is run by Nesta Investment Management, a wholly-owned subsidiary of Nesta, the UK’s innovation foundation. It is authorised by the Financial Conduct Authority to manage and invest funds on behalf of Nesta and external investors. More information is available atwww.nestainvestments.org.uk

About GSTC Health Innovations Ltd: A wholly owned subsidiary of Guy’s and St Thomas’ Charity, an independent charitable foundation which supports new ideas to tackle major health and care challenges in Lambeth and Southwark. Find out more at www.gsttcharity.org.uk and follow @GSTTCharity on Twitter.

About Genera: A leading technology company providing specialist software for healthcare. The company is headquartered in Sheffield, UK and has offices in Glasgow, UK. More information can be found at www.generacare.uk

For all media enquiries, please contact Laura Scarrott in Nesta’s press office: [email protected] / 0207 438 2697